Rick Doblin

Dr. Rick Doblin (founder and president of the Multidisciplinary Association for Psychedelic Studies, and one of the most influential figures in psychedelic science) returns to Mayim Bialik's Breakdown for one of the most controversial and eye-opening conversations on psychedelics we've had yet. From the shocking experiment where scientists gave MDMA to an octopus, to why ibogaine may be the most powerful AND dangerous psychedelic ever studied, this episode explores the future of psychedelic therapy, trauma healing, addiction recovery, policy reform, and human consciousness itself. We break down Trump’s new executive order accelerating psychedelic research and what it could mean for the future legalization of psychedelic-assisted therapy in America. Dr. Doblin explains why veterans suffering from PTSD and disabilities have become central to bipartisan support for psychedelics, and why this issue is now reshaping politics on both sides of the aisle. We also dive deep into ibogaine: its mysterious origins, its ability to help reset opioid addiction, its connection to ancestral memory and intergenerational trauma, why it carries serious risks, and why Dr. Doblin still believes its benefits may outweigh the dangers. He also shares his own profound ibogaine experience that helped him confront perfectionism and his fear of death. Dr. Doblin discusses: - How psychedelics help people integrate trauma - Why psychedelics are generally considered non-addictive - Difference between recreational vs therapeutic psychedelic use - Why psychedelic treatment should be customized to each patient - Importance of integration, peer support, and paying attention to dreams after treatment - Measures of success in MDMA-assisted couples therapy - Origins of the opioid epidemic - "Psychedelic churches": How organizations are openly operating under the umbrella of religion - Capitalism vs democratizing the benefits of psychedelic medicine - How a better psychedelic therapy model could be built - Why transparency is critical for science-backed drug policy reform - When psychedelics may realistically enter the open market - Dr. Doblin’s long-term vision for a psychedelic-informed public As psychedelic research rapidly expands worldwide, this conversation explores the science, politics, risks, ethics, and revolutionary potential behind one of the fastest-growing movements in mental health and medicine! DISCLAIMER: MBB is not providing medical or legal advice. Listeners should speak to their doctor before engaging in any course of psychedelic protocols. Psychedelics are still illegal in many places - MBB is not encouraging engaging in illegal substance use, but simply sharing the latest scientific insights from our guests. Learn more about MAPS & their research: https://maps.org/ To learn more about the world’s largest psychedelic conference, Psychedelic Science , taking place in Denver, CO next year, visit: https://virtualtrip.maps.org/ Follow us on Substack for Exclusive Bonus Content: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://bialikbreakdown.substack.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BialikBrea

Dr. Rick Doblin (founder and president of the Multidisciplinary Association for Psychedelic Studies, and one of the most influential figures in psychedelic science) returns to Mayim Bialik's Breakdown for one of the most controversial and eye-opening conversations on psychedelics we've had yet. From the shocking experiment where scientists gave MDMA to an octopus, to why ibogaine may be the most powerful AND dangerous psychedelic ever studied, this episode explores the future of psychedelic therapy, trauma healing, addiction recovery, policy reform, and human consciousness itself. We break down Trump’s new executive order accelerating psychedelic research and what it could mean for the future legalization of psychedelic-assisted therapy in America. Dr. Doblin explains why veterans suffering from PTSD and disabilities have become central to bipartisan support for psychedelics, and why this issue is now reshaping politics on both sides of the aisle. We also dive deep into ibogaine: its mysterious origins, its ability to help reset opioid addiction, its connection to ancestral memory and intergenerational trauma, why it carries serious risks, and why Dr. Doblin still believes its benefits may outweigh the dangers. He also shares his own profound ibogaine experience that helped him confront perfectionism and his fear of death. Dr. Doblin discusses: - How psychedelics help people integrate trauma - Why psychedelics are generally considered non-addictive - Difference between recreational vs therapeutic psychedelic use - Why psychedelic treatment should be customized to each patient - Importance of integration, peer support, and paying attention to dreams after treatment - Measures of success in MDMA-assisted couples therapy - Origins of the opioid epidemic - "Psychedelic churches": How organizations are openly operating under the umbrella of religion - Capitalism vs democratizing the benefits of psychedelic medicine - How a better psychedelic therapy model could be built - Why transparency is critical for science-backed drug policy reform - When psychedelics may realistically enter the open market - Dr. Doblin’s long-term vision for a psychedelic-informed public As psychedelic research rapidly expands worldwide, this conversation explores the science, politics, risks, ethics, and revolutionary potential behind one of the fastest-growing movements in mental health and medicine! DISCLAIMER: MBB is not providing medical or legal advice. Listeners should speak to their doctor before engaging in any course of psychedelic protocols. Psychedelics are still illegal in many places - MBB is not encouraging engaging in illegal substance use, but simply sharing the latest scientific insights from our guests. Learn more about MAPS & their research: https://maps.org/ To learn more about the world’s largest psychedelic conference, Psychedelic Science , taking place in Denver, CO next year, visit: https://virtualtrip.maps.org/ Rula patients typically pay $15 per session when using insurance. Connect with quality therapists and mental health experts who specialize in you at https://www.rula.com/break/ #rulapod Text BREAKDOWN to 64000 to get 20% off all IQBAR products, plus FREE shipping. Message and data rates may apply. Head to https://www.Superpower.com and use code BREAK at checkout for $20 off your membership. Unlock your new health intel

In this episode of the Ayahuasca Podcast, host Sam Believ sits down with Rick Doblin, Ph.D., the visionary founder of MAPS (Multidisciplinary Association for Psychedelic Studies). Rick has spent over 40 years leading the "Psychedelic Renaissance," moving MDMA through rigorous FDA clinical trials to treat PTSD and advocating for a post-prohibition world. Rick shares his profound journey—from a draft resistor in the 70s to a global leader in drug policy—explaining why he believes humanity is currently in a "race between consciousness and catastrophe." Key Discussion Points 04:15 – The Origins of Passion: Rick describes his upbringing in the shadow of the Holocaust and the Cuban Missile Crisis, which led to a lifelong quest to bridge the gap between human intellectual power and spiritual maturity. 09:30 – The Bar Mitzvah That Wasn't: Why Rick’s first LSD trip at 17 felt like the true "rite of passage" his traditional Bar Mitzvah failed to provide, sparking his interest in ancient transformative rituals. 13:45 – The "Hitler Within": A vulnerable recount of a DMT and Ketamine sequence in 1984 where Rick realized that the capacity for evil exists within everyone, leading to his mission for "mass mental health." 18:20 – The Birth of MAPS (1986): Navigating the DEA crackdowns of the 80s and deciding that medicalization through the FDA was the only viable path forward for psychedelics. 24:50 – A Global "Ayahuasca Day"? Sam and Rick discuss the potential of cultural integration—moving psychedelics from the counterculture to the mainstream as a tool for societal sanity. 29:10 – The Inflection Point: Rick reflects on the irony of President Trump’s executive order to accelerate psychedelic approvals and what it means for bipartisan support. 34:00 – Inner Work as a Global Necessity: Discussing Carl Jung’s warning that "the only real danger now is man himself" and how psychedelics can help us manage our own destructive capacities. 39:15 – Post-Apocalyptic Utopia: Exploring the vision of a world where technology handles labor, leaving humanity to focus on poetry, art, music, and consciousness. The MAPS Strategy: From Criminal to Clinical Rick explains that the strategy for the last 40 years has been to "go where the suffering is." By focusing on treatment-resistant PTSD, MAPS has been able to show that these substances are not just "party drugs" but powerful tools for clinical healing. The Race Between Consciousness and Catastrophe Rick posits that as our technological capabilities (AI, nuclear energy, etc.) grow, our emotional and spiritual development must keep pace. Without a shift in consciousness, our advancements become tools for destruction. Learn more about Rick Doblin and MAPS: Website: maps.org Rick’s TED Talk: The future of psychedelic-assisted psychotherapy Experience Authentic Healing: Are you seeking your own "inner transformation"? Visit ayahuascaincolombia.com to learn about our retreats in the heart of Colombia.

Can MDMA-assisted therapy solve the world’s most deep-seated conflicts? In this episode of Talks 21, we sit down with Rick Doblin, the visionary founder of MAPS (Multidisciplinary Association for Psychedelic Studies). Rick has spent over 40 years working tirelessly to transitionpsychedelics from counterculture to FDA-approved medicine. We dive deep into Rick’s personal journey – from his first encounters with LSD and the influence of Stan Grof, to his strategic battle against the DEA and the founding of MAPS in 1986. Rick candidly shares the mistakes made during the commercialisation of MDMA and his radical vision for "Net Zero Trauma" by 2070. Whether you are interested in the science of healing, the politics of drug reform, or the potential for psychedelics to foster peace in regions like Israel and Palestine, this conversation offers a profound look at the courage required to change the world. In this episode, we discuss: 🔹 The impact of the Holocaust and the Vietnam War on Rick’s mission. 🔹 The strategic shift from individual therapy to cultural and policy change. 🔹 The current status of the FDA approval for MDMA in the United States. 🔹 How to build bridges with those who think differently to find common ground. 🔹 Rick’s philosophy: focus on effort over outcome to build a lasting legacy. 🔗 You can support MAPS by sharing resources, joining upcoming events, or participating in their educational programs. Consider engaging in community conversations, volunteering, or supporting ongoing research to help shape the future of psychedelic medicine : www.maps.org Chapters 0:00:00 Theme song 0:00:13 Introduction 00:01:32 Rick’s Path to Psychedelics 00:18:22 Shifting Focus: From Individual Therapy to Public Policy 00:25:02 The Biggest Mistake in Building MAPS 00:31:46 The Future of MDMA Approval in the United States 00:34:58 A Vision for 2070: Achieving Net Zero Trauma 00:45:21 Healing Global Conflicts with MDMA 00:51:13 How to Overcome Fear and Spread Courage 01:03:45 Rick Doblin’s Legacy and Life’s Work 🔔 Subscribe to the channel and watch more interviews: https://www.youtube.com/channel/UCaJaxm7F1tK58bEnVoVliqg?sub_confirmation=1 Listen to the Talks 21 podcast also on: 🎧 Spotify → https://bit.ly/spotify-talks21 🎧 Apple Podcasts → https://apple.co/3VWWzwv 🌐 Official website of Karel Janeček: https://www.kareljanecek.com 📲 Follow Karel Janeček on social media: Instagram → https://www.instagram.com/karel252/ Facebook → https://www.facebook.com/kareljanecekcz 📩 Want to receive new episodes by email? Subscribe to the newsletter on the website. 💬 Do you have a guest suggestion or feedback? Write to us at: media@kareljanecek.com

Mental health conditions like depression, PTSD, and trauma related disorders remain difficult to treat, especially when underlying cognitive and emotional patterns persist over time. Emerging research suggests psychedelic assisted therapies may work by temporarily changing how the brain processes information and the sense of self. In this episode of Extend, we continue our conversation with Dr. Rick Doblin, founder of MAPS, to explore the mechanisms behind psychedelic therapy. We break down how compounds like LSD may reduce activity in the default mode network, how this shift affects perception and emotional processing, and why integration is essential for translating short term insights into lasting change. We also explore how traditional practices like ayahuasca combine psychological and spiritual frameworks, and how these approaches are shaping new perspectives on trauma, behavior change, and mental health treatment. Dr. Rick Doblin is the founder and executive director of MAPS (Multidisciplinary Association for Psychedelic Studies), the organization leading global research into psychedelic assisted therapies and working to develop evidence-based treatments for PTSD and other mental health conditions. What We Discuss: (1:01:22) LSD therapy for trauma and addiction (1:10:10) Psilocybin, creativity, and cognition (1:12:05) DMT, ego dissolution, and consciousness (1:18:21) Ayahuasca traditions and addiction recovery (1:26:39) MDMA therapy and intergenerational trauma (1:31:36) Ketamine clinics and treatment resistant depression Thank You to Our Sponsors: Timeline: Go to timeline.com/drshah to get 20% off your order. Learn more about Dr. Shah: Website: drshah.com Clinic: next-health.com Instagram: darshanshahmd Learn more about Dr. Rick Doblin: Website: maps.org Instagram: rickdoblinphd X: @RickDoblin

Depression, PTSD, and trauma related disorders continue to challenge modern medicine, even as our understanding of the brain and consciousness rapidly evolves. New research suggests that certain therapies may help unlock deeper healing by combining neuroscience, psychology, and carefully guided experiences. In this episode of Extend, we sit down with Dr. Rick Doblin, founder of MAPS, to unpack the science and history behind psychedelic assisted therapy and its potential role in mental health treatment. We break down the research behind MDMA assisted therapy for PTSD, how psychedelics influence neuroplasticity and emotional processing, and why therapeutic context, preparation, and integration are essential for safe and meaningful outcomes. We also explore how psychedelic research is reshaping conversations around trauma, healing, and the future of psychiatry. Dr. Rick Doblin is the founder and executive director of MAPS (Multidisciplinary Association for Psychedelic Studies), the organization leading global research into psychedelic assisted therapies and working to develop evidence-based treatments for PTSD and other mental health conditions. What We Discuss: (01:55) The political origins of psychedelic prohibition (04:40) Ancient psychedelic traditions and the Eleusinian Mysteries (08:01) Dr. Rick Doblin's path to founding MAPS (10:34) Science, policy, and the future of psychedelic medicine (11:00) Expanding research on MDMA therapy (12:21) Psychedelic churches and religious freedom laws (15:42) Why context and safety shape psychedelic outcomes (16:20) Neuroplasticity and emotional processing (17:36) Bromo-LSD and non-psychedelic therapeutic compounds (20:39) Psychedelics and rewriting personal narratives (23:22) The Good Friday Experiment and mystical experiences (25:23) MDMA therapy and trauma processing (27:47) Psychedelics and alternatives to alcohol (30:30) Ketamine therapy and pharmaceutical incentives (36:16) MAPS, MDMA development, and commercialization (41:56) The FDA pathway for MDMA therapy (47:00) Global psychedelic research initiatives (56:51) Early LSD research in psychology …to be continued Thank You to Our Sponsors: Timeline: Timeline powered by Mitopure just dropped the price. Check it out at timeline.com/drshah and get an additional 20% off your first month with code DRSHAH. Learn more about Dr. Shah: Website: <a href= "https://www.

Perhaps the tools to face death— heal from trauma— and transform life—have been within us all along. In this special episode of Alive Again , host Dan Bush sits down with Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) and one of the most influential voices in psychedelic research today. Together, they explore how psychedelic-assisted therapy is changing the landscape of trauma recovery, end-of-life care, and the very nature of what it means to heal. Rick shares insights from decades of groundbreaking work using MDMA, LSD, and psilocybin in clinical settings—particularly for those facing terminal illness or deep psychological wounds. He discusses brain plasticity, the release of DMT at death, and the profound similarities between near-death experiences and guided psychedelic journeys. With warmth and depth, this episode moves between the personal and the universal—grief, meaning, mortality, and the liminal spaces where transformation begins. Whether you're curious about the science or seeking a deeper understanding of the human spirit, this conversation offers a powerful look at how we might approach death—not with fear, but with expanded awareness. More About Rick Doblin: Rick Doblin is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit that has been at the forefront of exploring the therapeutic potential of psychedelics for over 35 years. His groundbreaking work has helped transform how we approach healing, trauma recovery, and end-of-life care, particularly through the use of psychedelics like MDMA, psilocybin, and DMT. Rick’s dedication to this field has given countless individuals— and their families—hope, understanding, and peace in the face of immense challenges, including terminal illness. In our conversation, we explore the intersection of his work with the themes of this podcast: transformation, adaptation, and the profound mysteries surrounding death and near-death experiences. Important links based on our conversation with Rick: Psychedelic Science 2025 MAPS Integration Workbook Donate to MAPS — MAPS relies on financial support from people like you. If you support the advancement of psychedelic research, policy reform, and education, please make a donation to fuel their work. Social Media links: MAPS Instagram: @MAPS__org Facebook: Multidisciplinary Association for Psychedelic Studies (MAPS) Linkedin: Multidisciplinary Association for Psychedelic Studies (MAPS) Twitter (X): @MAPS Threads: @MAPS__org Bluesky: @mapsorg.bsky.social TikTok: @MAPS.org YouTube: @MAPSMDMA Rick Doblin Instagram: @RickDoblinPhD Facebook: Rick Doblin Twitter (X): @RickDoblin Linkedin: Rick Doblin * If you have a transformative experience to share, we’d love to hear your story. Please email us at aliveagainproject@gmail.com See <a href="https://omnystudio.

In this episode of Divergent States , we sit down with Rick Doblin , founder of MAPS (Multidisciplinary Association for Psychedelic Studies), for a raw, unscripted conversation on the future of psychedelic therapy, the dangers of hype, and the deeply personal reasons behind his decades-long mission. We go deep into: Why MDMA was criminalized and how Doblin outmaneuvered the DEA The hard lessons from MAPS' FDA rejection and what's next Parenting and psychedelics: how both Rick and 3L1T3 approach education with their kids The trauma epidemic—why it’s bigger than war, abuse, or addiction How psychedelics could help shift collective consciousness in an age of collapse Burning Man, the Zendo Project, and building a new kind of community Doblin shares stories of his first psychedelic trips, his rebellious roots, and his vision for a future where safe, supported altered states are a human right, not a privilege. This isn’t just policy talk, it’s soul talk. 👉 If you’re neurodivergent, psychedelic-curious, or just fed up with the way things are—this one’s for you. 🧠 Support the show : patreon.com/divergentstates 🎟️ Learn more about Psychedelic Science 2025: maps.org 🔬 Psychedelic Science 25 at https://www.psychedelicscience.org Thank you to our Visionary Collaborators on Patreon! Thank you to Flintwick for the music! Chapters 00:00 Introduction to Divergent States and MAPS 02:47 Rick Doblin's Journey and the Founding of MAPS 10:03 The Messianic Idea and Psychedelics 18:54 Psychedelics as Tools for Healing 19:00 Educating the Next Generation about Psychedelics 25:00 The Role of Psychedelics in Addressing Global Trauma 30:09 Psychedelics and the Future of Humanity 33:31 Revitalizing Spirituality and Cultural Contexts 34:45 Psychedelics and Responsible Use 36:11 Modern Rites of Passage through Music 37:57 Harm Reduction and Support at Festivals 39:19 Psychedelic Science 2025 Conference 41:35 Community and Collaboration in Psychedelic Research 43:42 Reflections on Policy and Progress 45:42 Navigating Politics and Science 49:35 Globalizing Access to Psychedelic Therapies 52:42 The Importance of Divergent Perspectives Send us Fan Mail The next course is a weekend intensive and will take place on June 6th and 7th from 8am-2:30pm PT. This is a great opportunity for professionals and European students to participate in our live training at a more accessible time. FiresideProject.org Download the app or text/call 62-FIRESIDE Zendo Project Our listeners get 10% off the Zendo Project SIT Program with the code DIVERGENTS10 Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you. Support the show Special Thanks to our Macrodosers, Super D and Mike, and our Thumbprint Tier member, Angie on Patreon! https://linktr.ee/3L1T3Mod

In this episode, we welcome Rick Doblin, Ph.D., the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and puppy, with three empty rooms from his children who have all graduated college and begun their life journeys. Learn more about Rick by listening to his Origin Story , watching his TED Talk , and watching his SSDP talk about lessons for political activism from a series of his psychedelic experiences. Watch Dr. Doblin's Ted Talk: https://www.ted.com/talks/rick_doblin_the_future_of_psychedelic_assisted_psychotherapy?subtitle=en Listen to his Origin Story: https://www.youtube.com/watch?v=4s_j2OJOhrI&ab_channel=PTTOW%21 Tune into his SSDP Talk: https://www.youtube.com/watch?v=d3X2YsG7-Nc&ab_channel=StudentsforSensibleDrugPolicy%28SSDP%29

When the path to healing hits a roadblock, what’s the next move? Rick Doblin, Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), takes us on a journey through the challenges and triumphs of bringing MDMA-assisted therapy closer to FDA approval. In this episode, learn about the resilience needed to overcome setbacks in the world of psychedelic therapy and the profound impact that combining psychedelics with therapy can have on healing. Rick doesn't shy away from the ethical dilemmas and the complexities of integrating these powerful substances into therapeutic settings. His optimism shines through as he discusses the growing bipartisan support and the cutting-edge research pushing this field forward. With his deep knowledge and unwavering commitment, Rick offers a glimpse into the future of psychedelic therapy that’s both realistic and hopeful. For anyone invested in consciousness expansion and the potential of psychedelics to transform lives, this conversation is not one to miss. Rick’s insights are a powerful reminder that the road to innovation is often challenging, but the rewards can be life-changing. Key Takeaways: [00:02:34] FDA setback and resilience. [00:06:24] FDA regulation concerns psychedelics. [00:08:35] Unleashing potential in leadership. [00:13:14] Psychedelics for compassionate use. [00:16:26] Couples therapy research. [00:20:07] Public education on psychedelics. [00:23:27] Drug policy reform efforts. [00:26:22] FDA's view on psychedelics. [00:30:25] Ethical considerations in psychedelic therapy. [00:34:25] Group therapy for cost-effective treatment. [00:37:30] Healing through relationships. [00:41:27] Psychedelic research setbacks. [00:43:23] Psychedelics and human consciousness. [00:46:31] Psychedelics and public perception. [00:51:14] Evolution of consciousness. Memorable Quotes: "If you believe that this sort of consciousness change is really important, it's something to recognize that psychedelics have been used for thousands of years — and even when they've been massively suppressed, they've never been able to be eliminated. There's something about psychedelics and human beings where some fraction of human beings will seek them out and will find benefits." [00:42:58] – Rick Doblin "I think it's about really this multiplicity of catalysts and the responsibility that we have as humans in this particular time of humanity is to really up our game and to think of ourselves collectively. We see what's happening with global warming — we see what's happening with nuclear weapons — we see what's happening with all sorts of concerns. And we need to figure out how to think as a collective, as humanity as a whole, instead of as my individual race, religion, nationality, socioeconomic status. And I think psychedelics and other things can help us with that." [00:51:03] – Rick Doblin Connect with Rick Doblin: Website: https://maps.org/ Instagram: https://www.instagram.com/rickdoblinphd Facebook: https://www.facebook.com/rickdoblin/ Twitter: https://x.com/rickdoblin Emails: rick@maps.org and Whitney@maps.org Connect with Modern Enlightenment:

Dr. Rick Doblin is the founder and former Executive Director of MAPS (Multidisciplinary Association for Psychedelic Studies)​ (Wikipedia)​. He has been a key figure in advancing research into the therapeutic potential of psychedelics and has been instrumental in promoting the legalization of psychedelics for medical use​ (MAPS)​. Dr. Rick Doblin's Work and Achievements: MAPS and Psychedelic Therapy: Dr. Doblin founded MAPS in 1986 with a vision to integrate psychedelics into the medical field for therapeutic uses. Under his leadership, MAPS has conducted pioneering research into the benefits of psychedelics, particularly MDMA, for treating various mental health conditions​ (Apple)​. Clinical Trials and Research: MAPS has completed Phase 3 trials for MDMA-assisted therapy for PTSD and continues to explore its efficacy across various contexts. Dr. Doblin’s research includes advocating for the legalization of MDMA-assisted therapy and educating medical professionals on its benefits​ (Psychedelics Today)​. Advocacy and Impact: Beyond research, Dr. Doblin has advocated for policy changes regarding psychedelics, emphasizing their potential to aid in treating mental health disorders and changing the perception of these substances​ (Nature)​. Documentary and Public Engagement: Dr. Doblin’s life and work are captured in the documentary "Prescription X," highlighting his journey to legalize psychedelics for therapeutic use, including the challenges and triumphs along the way​ (PS2023: The Virtual Trip)​. In this week's episode of "Road to Abundance," we welcome Dr. Rick Doblin, the founder of MAPS. We delve into his work in the field of psychedelic research, exploring how MAPS has paved the way for the integration of psychedelics into medical therapy. We discuss the ongoing trials and the benefits of psychedelic therapy for mental health, as well as Dr. Doblin’s advocacy for legalization. Join us for an enlightening conversation on the changing landscape of psychedelic medicine and its potential to revolutionize mental health treatment.Twitter: Rick Doblin Twitter - https://twitter.com/rickdoblin

Rick Doblin is the founder of MAPS (multidisciplinary association for psychodelic studies), which just complete phase 3 trials for using MDMA to treat PTSD. They have an astounding success rate curing PTSD with 67% and addition 21% seeing good progress towards healing... thats 88% success in helping people live better lives. https://www.maps.org